Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children’s Oncology Group Studies P9904 and P9905

The delayed intensification (DI) enhanced outcome for patients with acute lymphoblastic leukemia (ALL) treated on BFM 76/79 and CCG 105 after a prednisone-based induction. Childrens Oncology Group protocols P9904/9905 evaluated DI via a post-induction randomization for eligible National Cancer Insti...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Leukemia
Autors principals: Winick, Naomi, Martin, Paul L., Devidas, Meenakshi, Shuster, Jonathan, Borowitz, Michael J., Bowman, W. Paul, Larsen, Eric, Pullen, Jeanette, Carroll, Andrew, Willman, Cheryl, Hunger, Stephen P., Carroll, William L., Camitta, Bruce M.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7749787/
https://ncbi.nlm.nih.gov/pubmed/31728054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-019-0642-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars